Pages without language links

Jump to navigation Jump to search

The following pages do not link to other language versions.

Showing below up to 50 results in range #621 to #670.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. 2-methylbutyryl-coenzyme a dehydrogenase deficiency
  2. 2-methylcitrate dehydratase
  3. 2-methylcitrate synthase
  4. 2-methyleneglutarate mutase
  5. 2-methylisocitrate dehydratase
  6. 2-nitrophenol 2-monooxygenase
  7. 2-nitropropane dioxygenase
  8. 2-oxo-acid reductase
  9. 2-oxoadipate reductase
  10. 2-oxoaldehyde dehydrogenase (NAD+)
  11. 2-oxoaldehyde dehydrogenase (NADP+)
  12. 2-oxobutyrate synthase
  13. 2-oxoglutarate carboxylase
  14. 2-oxoglutarate decarboxylase
  15. 2-oxoglutarate synthase
  16. 2-oxoisovalerate dehydrogenase (acylating)
  17. 2-oxopent-4-enoate hydratase
  18. 2-oxopropyl-CoM reductase (carboxylating)
  19. 2-phosphoglycerate
  20. 2-phosphosulfolactate phosphatase
  21. 2-propanoyl-3-(4-isopropylphenyl)-tropane
  22. 2-pyrone-4,6-dicarboxylate lactonase
  23. 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase
  24. 20-alpha-dihydroprogesterone
  25. 20-hydroxyecdysone
  26. 2005–present Chikungunya outbreak
  27. 2006 Eagle III accident
  28. 2006 Mercy Air 2 accident
  29. 2006 North American E. coli outbreak
  30. 2007 WikiDoc Foundation Scholars
  31. 2009 SCAI Scientific Sessions Schedule
  32. 2013 ACCF/AHA Guideline The Hospitalized Patient
  33. 2017 ACC/AHA Hypertension Guidelines
  34. 2017 ACG guidelines for the indications to test for and to treat Helicobacter pylori infection
  35. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay
  36. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)
  37. 20alpha-hydroxysteroid dehydrogenase
  38. 21-Hydroxylase
  39. 21-Hydroxylase Deficiency (patient information)
  40. 21-Hydroxylase Deficiency CT
  41. 21-Hydroxylase Deficiency case study one
  42. 21-Hydroxylase Deficiency causes
  43. 21-Hydroxylase Deficiency classification
  44. 21-Hydroxylase Deficiency cost-effectiveness of therapy
  45. 21-Hydroxylase Deficiency differential diagnosis
  46. 21-Hydroxylase Deficiency epidemiology and demographics
  47. 21-Hydroxylase Deficiency future or investigational therapies
  48. 21-Hydroxylase Deficiency genotyping
  49. 21-Hydroxylase Deficiency historical perspective
  50. 21-Hydroxylase Deficiency history and symptoms

View ( | ) (20 | 50 | 100 | 250 | 500)